Amylyx Pharmaceuticals logo

Director, Quality Control and Analytical Development

Amylyx Pharmaceuticals

Cambridge, MARemotePosted 2 days ago$204,000 - $229,000/year
Full TimeDirector & AboveQuality (QA / QC)Pharmaceutical
Original posting ↗

Summary

The Director of Quality Control and Analytical Development (QC/AD) is responsible for managing a team that provides quality oversight of method development, method validation, in process, release and stability testing at contract laboratories and contract manufacturing facilities. This role will manage the day-to-day QC/AD activities to support the Amylyx pipeline including synthetic peptides, antisense oligonucleotides and small molecules of drug substance through finished goods across preclinical and late-phase clinical programs. The individual will interact with internal multidisciplinary teams (Preclinical R&D, External Manufacturing, CMC, Regulatory and Supply Chain) to ensure successful delivery of analytical strategy and key objectives to meet audacious program timelines.

Job description

The Opportunity

The Director of Quality Control and Analytical Development (QC/AD) is responsible for managing a team that provides quality oversight of method development, method validation, in process, release and stability testing at contract laboratories and contract manufacturing facilities. This role will manage the day-to-day QC/AD activities to support the Amylyx pipeline including synthetic peptides, antisense oligonucleotides and small molecules of drug substance through finished goods across preclinical and late-phase clinical programs. The individual will interact with internal multidisciplinary teams (Preclinical R&D, External Manufacturing, CMC, Regulatory and Supply Chain) to ensure successful delivery of analytical strategy and key objectives to meet audacious program timelines.

Responsibilities

  • Manage a team to provide quality control and analytical development oversight of programs across development and clinical products, ensuring patient safety and compliance with regulations.
  • Lead the relationship and budget with various CMO/CTLs for method establishment, development and qualification across Amylyx programs.
  • Manage specifications, reference standards, release testing and stability programs to ensure compliance, delivery of Certificates of Analysis and shelf life establishment ensuring clinical supply.
  • Lead method troubleshooting, optimization and phase appropriate validation for characterization, release and stability across multiple programs across active pharmaceutical ingredients (API), drug substance (DS) and drug product (DP).
  • Drive all analytical investigations of OOS, deviations, change controls, CAPAs, temperature excursions and troubleshooting with CMO/CTLs.
  • Author, review and approve documentation including technical reports, SOPs, test methods, specifications and CMC sections of regulatory filings (IND/IMPD and/or NDA/BLA).
  • Participate in regular meetings held by the Tech Ops and Quality organization to represent Amylyx QC/AD at cross-functional meetings to develop strategies and deliver on key objectives.
  • Travel may be required up to 10%, which may include on-site review of third-party operations

Requirements

  • Minimum 10-12 years and BA/BS, 8+ years and MA/MS, 5+ years PhD of experience within the Pharmaceutical or Biotechnology industry.
  • Must have worked in a quality control and/or analytical development role for 5+ years.
  • Managerial/supervisory experience of a small team is required.
  • Technical expertise in method development and validation of complex GC, GC/MS, HPLC, LC/MS, ICP/MS analytical methods for isolation, detection, identification, and quantification of both drug substances and drug products of small molecules or/and large molecules.
  • Exhibit strong technical skills and the ability to critically evaluate raw data, trend analysis and present results to all levels of the organization and external vendors.
  • Experience with authoring CMC sections of and regulatory filing requirements.
  • Knowledgeable in FDA cGMP regulations, Eudralex and ICH Guidance, as well as other Biopharma industry guidance and regulations.
  • Highly collaborative team player with strong communication skills.
  • Experience with small molecules, peptides, sterile manufacturing and oral dosage forms is highly preferred.

Work Location and Conditions

  • At Amylyx, we proudly support remote work opportunities within the United States. However, due to business considerations related to health insurance coverage and state tax regulations, we are unable to hire employees who reside and/or work in certain states. Currently, we are not considering applicants from Alaska and Hawaii.
  • You will be expected to travel to our corporate location in Cambridge, MA several times a year and attend other company-related events as necessary and requested.
  • You must have access to work in setting which enables meeting all requirements of the role (including privacy, reliable internet access, phone, ability to video conference, etc.) at your remote location.

Requirements

  • Minimum 10-12 years and BA/BS, 8+ years and MA/MS, 5+ years PhD of experience within the Pharmaceutical or Biotechnology industry
  • Must have worked in a quality control and/or analytical development role for 5+ years
  • Managerial/supervisory experience of a small team is required
  • Technical expertise in method development and validation of complex GC, GC/MS, HPLC, LC/MS, ICP/MS analytical methods
  • Ability to critically evaluate raw data, trend analysis and present results to all levels of the organization and external vendors
  • Experience with authoring CMC sections of and regulatory filing requirements
  • Knowledgeable in FDA cGMP regulations, Eudralex and ICH Guidance
  • Highly collaborative team player with strong communication skills
  • Experience with small molecules, peptides, sterile manufacturing and oral dosage forms is highly preferred

Benefits

  • Performance-based bonuses
  • Equity awards
  • Comprehensive benefits package

Company overview

Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company based in Cambridge, Massachusetts, founded in 2013 by co-CEOs Josh Cohen and Justin Klee. The company specializes in developing novel therapies for neurodegenerative diseases with high unmet medical needs, with a particular focus on amyotrophic lateral sclerosis (ALS), Wolfram syndrome, and post-bariatric hypoglycemia. Amylyx's lead investigational therapy, AMX0035, received FDA approval for ALS treatment under the brand name RELYVRIO in September 2022. The company employs a rigorous scientific approach to target multiple pathological pathways in neurodegeneration, with additional pipeline candidates including avexitide for metabolic disorders and AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS. With a team of 201-500 employees, Amylyx combines therapeutic development expertise with commercialization capabilities to address some of medicine's most challenging conditions.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.